文献速递前列腺增生与排尿功能障碍

峰值尿流率能否预测当前症状轻微或无下尿路症状男性的新发下尿路症状?REDUCE研究结果

Does Peak Urine Flow Rate Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from REDUCE.
PubMed 文献 · J Urol · 2017-04-17

基于REDUCE试验中3140例I-PSS<8的男性,每6个月评估I-PSS共4年,用多因素Cox模型分析峰值尿流率与新发下尿路症状的关联。结果显示峰值尿流率降低与发病风险升高独立相关(连续变量p=0.002),非那雄胺组与安慰剂组结果相似。

要点

  • 在I-PSS<8的男性中,峰值尿流率降低与新发下尿路症状风险升高独立相关(p=0.002)。
  • 单因素分析中峰值尿流率10–14.9 ml/s者HR 1.39(p=0.011),<10 ml/s者HR 1.67(p<0.001)。
  • 多因素分析中10–14.9 ml/s组HR 1.26但未达统计学显著(p=0.071)。

核心结论

  • 在当前症状轻微或无下尿路症状的男性中,峰值尿流率降低与新发下尿路症状独立相关。
  • 作者认为若该结果被证实,这些男性应接受更密切的随访以发现新发下尿路症状。

研究设计与样本

  • 研究对象为REDUCE(Reduction by Dutasteride of Prostate Cancer Events)试验中3140例当前症状轻微或无下尿路症状(I-PSS<8)的男性。
  • REDUCE为随机试验,比较度他雄胺与安慰剂用于前列腺癌预防,入组者为前列腺特异抗原升高且活检阴性者。
  • 研究期间每6个月评估一次I-PSS,共4年。
  • 采用多因素Cox模型检验峰值尿流率与新发下尿路症状的关联,并校正多种基线特征与治疗分组。

主要发现

  • 多因素分析中,峰值尿流率作为连续变量降低与新发下尿路症状风险升高显著相关(p=0.002)。
  • 度他雄胺组与安慰剂组结果相似。
  • 单因素分析按峰值尿流率分组:≥15 ml/s、10–14.9 ml/s和<10 ml/s,10–14.9 ml/s组HR 1.39(p=0.011),<10 ml/s组HR 1.67(p<0.001),均与新发下尿路症状风险升高显著相关。
  • 多因素分析结果相似,但10–14.9 ml/s组未达统计学显著(HR 1.26,p=0.071)。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为若该结果被证实,这些男性应接受更密切的随访以发现新发下尿路症状。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We determined whether decreased peak urine flow is associated with future incident lower urinary tract symptoms in men with mild to no lower urinary tract symptoms. MATERIALS AND METHODS: Our population consisted of 3,140 men from the REDUCE (Reduction by Dutasteride of Prostate Cancer Events) trial with mild to no lower urinary tract symptoms, defined as I-PSS (International Prostate Symptom Score) less than 8. REDUCE was a randomized trial of dutasteride vs placebo for prostate cancer prevention in men with elevated prostate specific antigen and negative biopsy. I-PSS measures were obtained every 6 months throughout the 4-year study. The association between peak urine flow rate and progression to incident lower urinary tract symptoms, defined as the first of medical treatment, surgery or sustained and clinically significant lower urinary tract symptoms, was tested by multivariable Cox models, adjusting for various baseline characteristics and treatment arm. RESULTS: On multivariable analysis as a continuous variable, decreased peak urine flow rate was significantly associated with an increased risk of incident lower urinary tract symptoms (p = 0.002). Results were similar in the dutasteride and placebo arms. On univariable analysis when peak flow was categorized as 15 or greater, 10 to 14.9 and less than 10 ml per second, flow rates of 10 to 14.9 and less than 10 ml per second were associated with a significantly increased risk of incident lower urinary tract symptoms (HR 1.39, p = 0.011 and 1.67, p <0.001, respectively). Results were similar on multivariable analysis, although in the 10 to 14.9 ml per second group findings were no longer statistically significant (HR 1.26, p = 0.071). CONCLUSIONS: In men with mild to no lower urinary tract symptoms a decreased peak urine flow rate is independently associated with incident lower urinary tract symptoms. If confirmed, these men should be followed closer for incident lower urinary tract symptoms.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Simon RM, Howard LE, Moreira DM, et al. Does Peak Urine Flow Rate Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from REDUCE. J Urol. 2017. PMID: 28428110. doi:10.1016/j.juro.2017.04.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。